Understanding how glyoxalase 1 affects obesity and diabetes
Official title: Glyoxalase 1 and its Role in Metabolic Syndrome
Funded at University of Arizona · NIH-11049142 · Data updated 2026-11-12
This study is looking at how a protein called GLO1 affects weight gain, blood sugar levels, and liver health in mice, which could help us find new ways to treat obesity, Type 2 diabetes, and fatty liver disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project start | April 1, 2023 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $465,631 |
| NIH project number | 5R01DK133196-03 |
| Project ID | NIH-11049142 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are overweight or have been diagnosed with Type 2 diabetes or non-alcoholic fatty liver disease.
✕Less likely to help
Patients who are not overweight or do not have metabolic syndrome-related conditions may not benefit from this research.
What this research studies
This research investigates the role of glyoxalase 1 (GLO1) in the development of obesity, Type 2 diabetes (T2D), and non-alcoholic fatty liver disease (NAFLD). By using advanced techniques like CRISPR-Cas9, researchers have created mice that lack GLO1 to observe how this affects their weight, glucose tolerance, and liver health when fed a high-fat, high-sugar diet. The study aims to uncover the mechanisms by which GLO1 influences metabolic processes and could lead to new treatment strategies for these conditions.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that help manage or prevent obesity and Type 2 diabetes.
How similar studies have gone: Previous research has shown promising results in understanding metabolic pathways related to obesity and diabetes, suggesting that this approach could yield significant insights.
Where this research is happening
-
University of Arizona
Tucson, United States Active
Researchers
- Principal investigator: Galligan, James J — University of Arizona
- Study coordinator: Galligan, James J
Related research
Other NIH-funded projects on the same topics.
-
Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART
Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART
This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based therapy
This project looks at markers in pregnant women living with HIV who are on a DTG-containing regimen to understand why some develop metabolic problems during pregnancy.
-
Metabolic syndrome and brain support cells: how it may lead to Alzheimer’s disease
A researcher is studying how midlife metabolic problems like diabetes and obesity may disrupt brain cells that support neurons, potentially leading to Alzheimer's disease and related dementia in later life.
-
GLP-1 medicines to improve heart, kidney, and metabolic health for people with HIV and type 2 diabetes
A real-world study will look at how GLP-1 receptor agonists affect heart and kidney health and lifetime costs for people living with HIV and type 2 diabetes.
-
A new metabolic risk score to predict heart disease in Yup’ik Alaska Native adults
A new, questions-free way to measure heart-disease risk in Yup’ik Alaska Native adults by combining everyday health clues with home-life factors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.